Spectral mammography could be used to accurately measure breast density, thus helping to identify women at high risk for breast cancer, researchers said.
Spectral mammography could be used to accurately measure breast density, thus helping to identify women at high risk for breast cancer, researchers said.
Spectral mammography can provide far more information than standard mammography by showing the image at two different energy levels, helping quantify breast density, according to Sabee Molloi, PhD, professor and vice chairman of research for the department of radiological sciences at the University of California, Irvine. Molloi compared the two techniques to the differences between color television and black and white.
“We’re working to develop a an accurate measure of breast density,” Molloi said in a teleconference in advance of this week's annual meeting of the American Association of Physicists in Medicine, where his early research was presented. “It should be simple, accurate, and most importantly, ready to implemented with the common mammography screening.”
A woman with extremely dense breasts has up to four times the risk of breast cancer as a woman with fattier breasts, reserachrers said. Reading images of denser breasts is a challenge using standard mammography, because tumors are harder to see.
Molloi and colleagues used spectral mammography to image four models of breasts, representing different thicknesses. They found that spectral mammpgraphy could measure volumetric breast density in a screening exam with an error rate of less than 2 percent. Researchers are planning pilot studies to test spectral mammography as part of regular screening.
“Everyone could benefit from this emerging imaging technology,” Molloi said. “It could become a standard of care and help identify high-risk women.”
The mammogram on the left is high density and the one on the right is low density. Image courtesy AAPM.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.